Posted on 7/7/16
Can Vertex Pharmaceuticals Incorporated Bounce Back From Its 28.9% Drop?
IMAGE SOURCE: VERTEX PHARMACEUTICALS.What: So far, 2016 has been pretty rough on investors in Vertex Pharmaceuticals(NASDAQ:VRTX). Shares of the cystic fibrosis (CF) leader have fallen drastically . . .
Posted on 7/6/16
Syros Pharmaceuticals Closes IPO
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals (NASDAQ: SYRS) today announced the closing of its initial public offering of 4,600,000 shares of common stock at an offering price of . . .
Posted on 7/6/16
Sharps Compliance Acquires Citiwaste
Sharps Compliance Corp. (NASDAQ:SMED), a leading full-service national provider of comprehensive waste management solutions including medical
Posted on 7/6/16
Better Buy: Ionis Pharmaceuticals vs. Alnylam Pharmaceuticals
IMAGE SOURCE: GETTY IMAGES.This biotech develops drugs that work by interfering with messenger ribonucleic acid (RNA) to prevent the prodution of disease-causing proteins. Shares of the . . .
Posted on 7/6/16
Why Alnylam Pharmaceuticals, Inc. Is Down 37.3% This Year
IMAGE SOURCE: GETTY IMAGES.What: Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), a clinical-stage biotech developing novel therapies based on RNA interference, tumbled earlier this year, and are . . .
Posted on 7/5/16
Bristol-Myers Squibb Acquires Cormorant Pharmaceuticals
Bristol-Myers Squibb Company (NYSE:BMY) and Cormorant Pharmaceuticals announced today that Bristol-Myers Squibb has acquired all of the outstanding capital stock of Cormorant
Posted on 7/5/16
3 Big Reasons Agios Pharmaceuticals, Inc. Has Plunged 38% in 2016
IMAGE SOURCE: GETTY IMAGES.What: Shares of Agios Pharmaceuticals (NASDAQ:AGIO), a clinical-stage biopharmaceutical company focused on the development of cancer therapeutics and drugs to treat metabolic disorders, . . .
Posted on 7/1/16
Bargain Buys: These 3 Biopharma Stocks Are All Down Big in 2016
The U.S. presidential election and the Brexit vote have combined to wreck havoc on biopharma stocks this year. On the bright side, these headwinds appear to . . .
Posted on 7/1/16
3 Reasons To Buy Biogen
Biotechnology stocks are regaining a bit of their luster lately; but that's done little to help boost shares in Biogen Inc. (NASDAQ:BIIB). In the wake of . . .
Posted on 7/1/16
Atrius Health Taps Proverb For New Branding Campaign
Proverb, a Boston-based branding and design agency, has been named design agency of record for Newton, Mass. – based healthcare provider Atrius Health, according to Managing . . .
Posted on 7/1/16
InspireMD Announces Pricing of Public Offering of Approximately $14.6 Million
InspireMD, Inc. (NYSE MKT: NSPR) , a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced the pricing of a "best . . .
Posted on 7/1/16
TESARO Announces Pricing of Public Offering of Common Stock
WALTHAM, Mass., June 30, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that it has priced an underwritten public offering of an aggregate of 4,650,000 . . .
Posted on 7/1/16
Planet Fitness Ranked One Of The Best Franchises In America By Forbes
Planet Fitness, Inc. (NYSE: PLNT), one of the largest and fastest-growing franchisors and operators of fitness centers in the U.S., ranked No. 4 on Forbes annual . . .
Posted on 6/30/16
EyeGate Completes $3.77 Million Registered Direct Offering
WALTHAM, Mass., June 30, 2016 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG), a specialty pharmaceutical company that focuses on developing and commercializing therapeutics and drug delivery . . .
Posted on 6/30/16
UMN Pharma Joins Protein Sciences' International Zika Vaccine Consortium
USA and Japan -- Protein Sciences Corporation, manufacturer of Flublok® influenza vaccine, and UMN Pharma Inc. (Akita, Akita prefecture, Japan) announced today that UMN has signed . . .
Posted on 6/30/16
Cyteir Therapeutics Receives $2M Grant from National Cancer Institute
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cyteir Therapeutics, Inc., a leader in the development of novel therapeutics based on the biology of DNA repair, today announced that it has received . . .
Posted on 6/30/16
HealthEdge Recognized By Healthcare Informatics For Second Year In A Row
BURLINGTON, Mass.--(BUSINESS WIRE)--HealthEdge®, provider of the only integrated financial, administrative and clinical platform for health insurers, today announced that the company has again been recognized as . . .
Posted on 6/30/16
Syros Pharmaceuticals Prices IPO
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals today announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a public offering price of . . .
Posted on 6/29/16
Here's Why bluebird bio's Shares Dropped 10% on Monday
What's happening: Shares of the clinical-stage gene therapy company bluebird bio(NASDAQ:BLUE) fell by 10% yesterday on higher than normal volume.IMAGE SOURCE: GETTY IMAGES.Why it's happening: The . . .
Posted on 6/28/16
VillageMD Forms New Joint Venture with the Two Largest Physician Practices in New Hampshire
CHICAGO--(BUSINESS WIRE)--VillageMD, a leading primary care-focused management services organization, has partnered with the two largest independent physician groups in New Hampshire, Derry Medical Center and Southern . . .
Posted on 6/28/16
ProEx Physical Therapy Names Cameron Bliss as Exercise Technician
ProEx, a physical therapist owned private practice specializing in orthopedics, spine and sports medicine announces that Cameron
Posted on 6/28/16
When Will Gilead Sciences, Celgene, and CVS Health Hit $100 Again?
IMAGE SOURCE: GETTY IMAGES.It's been a rough year to be an investor in Gilead Sciences (NASDAQ:GILD), Celgene(NASDAQ:CELG), or CVS Health (NYSE:CVS). All three of these high-quality . . .
Posted on 6/28/16
Here's Why Merrimack Pharmaceuticals' Stock Has Been Getting Crushed in 2016
IMAGE SOURCE: GETTY IMAGESWhat: Shares of Merrimack Pharmaceuticals (NASDAQ:MACK) have fallen by close to 28% this year, according to data from S&P Global Market Intelligence. Even . . .
Posted on 6/28/16
Selecta Biosciences Announces Closing of Initial Public Offering
WATERTOWN, Mass., June 27, 2016 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq:SELB) today announced the closing of its initial public offering of 5,000,000 shares of common . . .
Posted on 6/27/16
EyeGate Announces $3.77 Million Registered Direct Offering
WALTHAM, Mass., June 27, 2016 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG), a specialty pharmaceutical company that focuses on developing and commercializing therapeutics and drug delivery . . .
Boston
